Healthcare - Biotechnology - NASDAQ - GB
$ 1.79
-5.79 %
$ 7.77 M
Market Cap
-0.53
P/E
BALANCE SHEET
5.48 M
ASSETS
345 K
LIABILITIES
5.37 M
EQUITY
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition
Virax Biolabs Group Limited
| Current Assets | 4.38 M |
| Cash & Short-Term Investments | 3.59 M |
| Receivables | 218 K |
| Other Current Assets | 573 K |
| Non-Current Assets | 1.1 M |
| Long-Term Investments | 0 |
| PP&E | 1.1 M |
| Other Non-Current Assets | 0 |
| Current Liabilities | 169 K |
| Accounts Payable | 45.6 K |
| Short-Term Debt | 48 K |
| Other Current Liabilities | 75.3 K |
| Non-Current Liabilities | 176 K |
| Long-Term Debt | 176 K |
| Other Non-Current Liabilities | 0 |
Balance Sheet
Millions
| Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 | Mar-2020 | |
|---|---|---|---|---|---|
| ASSETS | |||||
| Cash & Cash Equivalents | 3.6 | 9.4 | 21.8 K | 17.6 K | 22.6 K |
| Short Term Investments | 77.3 K | 49.3 K | 6 K | 0 | 0 |
| Receivables | 0.2 | 0 | 0 | 928 | 0 |
| Inventory | 60.4 K | 24.1 K | 21 K | 21.1 K | 0 |
| Other Current Assets | 0.5 | 0.3 | 6 K | 0 | 0 |
| Total Current Assets | 4.4 | 9.6 | 48.7 K | 39.6 K | 22.6 K |
| PP&E | 1.1 | 0 | 0 | 0 | 0 |
| Intangible Assets | 49.8 K | 0.2 | 0 | 0 | 0 |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments | 0 | 0 | 0 | 54.5 K | 0 |
| Other Long Term Assets | 49.8 K | (0.2) | 0 | 0 | 0 |
| Other Assets | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 5.5 | 9.8 | 48.7 K | 94.1 K | 22.6 K |
| LIABILITIES | |||||
| Accounts Payable | 45.6 K | 0.2 | 0.8 | 0.2 | 0.2 |
| Short Term Debt | 48 K | 0.1 | 0 | 0 | 0.8 |
| Other Current Liabilities | 63.1 K | 0.5 | 0.4 | 0.7 | 0.3 |
| Total Current Liabilities | 0.2 | 0.9 | 1.2 | 0.9 | 1.2 |
| Long Term Debt | 0.2 | 0 | 0 | 0 | 0 |
| Deferred Tax Income | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | 0.3 | 0.9 | 1.2 | 0.9 | 1.2 |
| EQUITY | |||||
| Common Stock | 2.57 K | 1.56 K | 999 | 265 | 104 |
| Retained Earnings | (18.5) | (11.8) | (6.3) | (4.6) | (4.0) |
| Other Accumulative Comprehensive Income/Loss | 23.9 | 20.9 | 5.4 | 4.0 | 2.9 |
| Total Equity | 5.1 | 8.9 | (1.2) | (0.8) | (1.2) |
| Total Liabilities and Equity | 5.5 | 9.8 | 48.7 K | 94.1 K | 22.6 K |
| SHARES OUTSTANDING | |||||
| Common Shares Outstanding | 2.0 | 1.1 | 1.1 | 1.1 | 1.1 |